The cancer-immunity cycle underscores dendritic cells' (DC) pivotal role in priming CD4+ and CD8+ T-cells through presentation of tumor-associated antigens (TAAs) in tumor-draining lymph nodes (TDLN) [4]. The gene discussed is CD8A; the disease is neoplasm.